Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125763261 | 12576326 | 1 | I | 20160307 | 20160707 | 20160720 | 20160720 | EXP | JP-TAKEDA-2016TUS012444 | TAKEDA | 85.00 | YR | F | Y | 0.00000 | 20160720 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125763261 | 12576326 | 1 | PS | Feburic | FEBUXOSTAT | 1 | Oral | 20 MG, QD | U | 21856 | 20 | MG | TABLET | QD | |||||
| 125763261 | 12576326 | 2 | SS | SAMSCA | TOLVAPTAN | 1 | Oral | 15 MG, QD | U | 0 | 15 | MG | TABLET | QD | |||||
| 125763261 | 12576326 | 3 | SS | DIART | AZOSEMIDE | 1 | Oral | 30 MG, QD | U | 0 | 30 | MG | TABLET | QD | |||||
| 125763261 | 12576326 | 4 | SS | WARFARIN | WARFARIN | 1 | Oral | 1.75 MG, QD | U | 0 | 1.75 | MG | TABLET | QD | |||||
| 125763261 | 12576326 | 5 | SS | ARTIST | CARVEDILOL | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD | |||||
| 125763261 | 12576326 | 6 | SS | PIMOBENDAN | PIMOBENDAN | 1 | Oral | 2.5 MG, QD | U | 0 | 2.5 | MG | TABLET | QD | |||||
| 125763261 | 12576326 | 7 | SS | FERROUS SULFATE. | FERROUS SULFATE | 1 | Oral | 210 MG, QD | U | 0 | 210 | MG | TABLET | QD | |||||
| 125763261 | 12576326 | 8 | SS | RUEFRIEN | GLUTAMINESODIUM GUALENATE | 1 | Oral | 2.01 G, 1/WEEK | U | 0 | 2.01 | G | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125763261 | 12576326 | 1 | Product used for unknown indication |
| 125763261 | 12576326 | 2 | Product used for unknown indication |
| 125763261 | 12576326 | 3 | Product used for unknown indication |
| 125763261 | 12576326 | 4 | Product used for unknown indication |
| 125763261 | 12576326 | 5 | Product used for unknown indication |
| 125763261 | 12576326 | 6 | Product used for unknown indication |
| 125763261 | 12576326 | 7 | Product used for unknown indication |
| 125763261 | 12576326 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125763261 | 12576326 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125763261 | 12576326 | Hyperammonaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |